Advertisement

Toxicokinetics of Nano Materials After the Intratracheal Administration

Chapter
  • 97 Downloads
Part of the Current Topics in Environmental Health and Preventive Medicine book series (CTEHPM)

Abstract

Toxicokinetic data is important to evaluate the toxicity of nano materials because burden and toxicity for each organ can be different among particles even at same burden. Intratracheal administration has been proposed to use as screening method for the evaluation of inhalation toxicity to nano materials. In the manuscript, toxicokinetic test methods, deposition/clearance/distribution, and toxicokinetic models of nano materials after intratracheal administration mainly conducted in METI Project are described. By using XRF and ICP-MS, the deposition, clearance, and distribution were determined in the animal tests. Insoluble and poorly soluble nano particles detected in lung were 44–100% at 1–3 days after intratracheally administration, while poorly soluble coarse particle, which is likely to be trapped at bronchiole, detected in lung at 1–3 days after intratracheally administration were only 5–40%. Twenty-eight days after the intratracheal administration, the lung contained <1% (soluble NiO), 37–90% (poorly soluble NiO and Al(OH)3-coated TiO2), 40–62% (insoluble TiO2 particles), 11–30% (amorphous SiO2), and 21–63% (crystal SiO2) of administered doses. Translocation from lung to extrapulmonary organs was quite low except for lymph nodes.

Keywords

Animal test ICP-MS XRF Deposition Clearance Distribution Compartment model 

Notes

Acknowledgment

This work is part of the research program “Development of innovative methodology for safety assessment of industrial nanomaterials,” supported by the Ministry of Economy, Trade and Industry (METI) of Japan.

References

  1. 1.
    RIVM (National Institute for Public Health and the Environment, Netherlands). Multiple path particle dosimetry model (MPPD v.3.04): a model for human and rat airway particle dosimetry, Bilthoven, The Netherlands. RIVA report 650010030, 2017.Google Scholar
  2. 2.
    Shinohara N, Oshima Y, Kobayashi T, Imatanaka N, Nakai M, Ichinose T, Sasaki T, Kawaguchi K, Zhang G, Gamo M. Pulmonary clearance kinetics and extrapulmonary translocation of seven titanium dioxide nano and submicron materials following intratracheal administration in rats. Nanotoxicology. 2015;9(8):1050–8.CrossRefGoogle Scholar
  3. 3.
    Shinohara N, Oshima Y, Kobayashi T, Imatanaka N, Nakai M, Ichinose T, Sasaki T, Zhang G, Fukui H, Gamo M. Dose-dependent clearance kinetics of intratracheally administered titanium dioxide nanoparticles in rat lung. Toxicology. 2014;325(5):1–11.CrossRefGoogle Scholar
  4. 4.
    Shinohara N, Zhang G, Oshima Y, Kobayashi T, Imatanaka N, Nakai M, Sasaki T, Kawaguchi K, Gamo M. Kinetics and dissolution of intratracheally administered nickel oxide nanomaterials in rats. Part Fibre Toxicol. 2017;14(1):48.CrossRefGoogle Scholar
  5. 5.
    Zhang G, Shinohara N, Kano H, Senoh H, Suzuki M, Sasaki T, Fukushima S, Gamo M. Quantitative evaluation of local pulmonary distribution of TiO2 in rats following single or multiple intratracheal administrations of TiO2 nanoparticles using X-ray fluorescence microscopy. J Appl Toxicol. 2016;36(10):1268–75.CrossRefGoogle Scholar
  6. 6.
    Zhang G, Shinohara N, Kano H, Senoh H, Suzuki M, Sasaki T, Fukushima S, Gamo M. Quantitative evaluation of the pulmonary microdistribution of TiO2 nanoparticles using XRF microscopy after intratracheal administration with a microsprayer in rats. J Appl Toxicol. 2015;35(6):623–30.CrossRefGoogle Scholar
  7. 7.
    Zhang G, Shinohara N, Oshima Y, Kobayashi T, Imatanaka N, Kawaguchi K, Gamo M. Comparison of the local pulmonary distribution of nanoparticles administered intratracheally to rats via gavage needle or microsprayer delivery devices. J Appl Toxicol. 2017;37(4):502–7.CrossRefGoogle Scholar
  8. 8.
    AIST (National Institute of Advanced Industrial Science and Technology). Final report of the program “Development of innovative methodology for safety assessment of industrial nanomaterials”, supported by the Ministry of Economy, Trade and Industry (METI) of Japan, Tokyo, Japan, 2016.Google Scholar
  9. 9.
    Shinohara N, Nakazato T, Ohkawa K, Tamura M, Kobayashi N, Morimoto Y, Oyabu T, Myojo T, Shimada M, Yamamoto K, Tao H, Ema M, Naya M, Nakanishi J. Long-term retention of pristine multi-walled carbon nanotubes in rat lungs after intratracheal instillation. J Appl Toxicol. 2016;36(4):501–9.CrossRefGoogle Scholar
  10. 10.
    Madl AK, Wilson DW, Segall HI, Pinkerton KE. Alteration in lung particle translocation, macrophage function, and microfilament arrangement in monocrotaline-treated rats. Toxicol Appl Pharmacol. 1998;153:28–38.CrossRefGoogle Scholar
  11. 11.
    Oberdörster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect. 1994;102:173–9.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Ferin J, Oberdörster G, Penney DP. Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol. 1992;6:535–42.CrossRefGoogle Scholar
  13. 13.
    Kasai T, Umeda Y, Ohnishi M, Mine T, Kondo H, Takeuchi T, Matsumoto M, Fukushima S. Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats. Part Fibre Toxicol. 2016;13:53.CrossRefGoogle Scholar
  14. 14.
    ICRP. Human respiratory tract model for radiological protection. A report of a task group of the International Commission on Radiological Protection (ICRP publication 66). International Commission on Radiological Protection, Pergamon, Edinburgh, 1994.Google Scholar
  15. 15.
    Stöber W, et al. Compartmental modeling of the long-term retention of insoluble particles deposited in the alveolar region of the lung. Fundam Appl Toxicol. 1989;13:823–42.CrossRefGoogle Scholar
  16. 16.
    Stöber W. Pock model simulations of pulmonary quartz dust retention data in extended inhalation exposures of rats. Inhal Toxicol. 1999;11:269–92.CrossRefGoogle Scholar
  17. 17.
    Kuempel ED, et al. A biomathematical model of particle clearance and retention in the lungs of coal miners I. Model development. Regul Toxicol Pharmacol. 2001;34:69–87.CrossRefGoogle Scholar
  18. 18.
    Gregoratto D, Bailey MR, Marsh JW. Modelling particle retention in the alveolar-interstitial region of the human lungs. J Radiol Prot. 2010;30:491–512.CrossRefGoogle Scholar
  19. 19.
    Oyabu T, Myojo T, Lee B, Okada T, Izumi H, Yoshiura Y, Tomonaga T, Li Y, Kawai K, Shimada M, Kubo M, Yamamoto K, Sasaki T, Morimoto Y. Biopersistence of NiO and TiO2 Nanoparticles Following Intratracheal Instillation and Inhalation. Int J Mol Sci. 2017;18:2557.CrossRefGoogle Scholar
  20. 20.
    Shinohara N, Nakazato T, Tamura M, Endoh S, Fukui H, Morimoto Y, Myojo T, Shimada M, Yamamoto K, Tao H, Yoshida Y, Nakanishi J. Clearance kinetics of fullerene C60 nanoparticles from rat lungs after intratracheal C60 instillation and inhalation C60 exposure. Toxicol Sci. 2010;118(2):564–73.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Research Institute of Science for Safety and Sustainability (RISS), National Institute of Advanced Industrial Science and Technology (AIST)TsukubaJapan

Personalised recommendations